Anticoagulants, Thrombolytics, and Antiplatelet Agents
Nov 10, 2022•1 hr 14 min•Season 1Ep. 37
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This week, Rob and Zach will be talking about Anticoagulants, Thrombolytics, and Antiplatelet Agents
We will be discussing the following topics within this episode on Anticoagulants, Thrombolytics, and Antiplatelet Agents!
- Hemostasis: Coagulation Cascade, Extrinsic + Intrinsic Pathway
- Anticoagulants:
- Heparin
- UFH
- LMWH
- Fondaparinux
- Direct Factor Inhibitors
- Xa Inhibitors:
- Rivaroxaban
- Apixaban
- Edoxaban
- Thrombin Inhibitors:
- Dabigatran
- Argatroban
- Bivalirudin
- Xa Inhibitors:
- Vitamin K Antagonists:
- Warfarin (Coumadin)
- Heparin
- Thrombolytics (tPA):
- Alteplase
- Reteplase
- Tenecteplase
- Streptokinase
- Urokinase
- Antiplatelets:
- Aspirin
- P2y12 Receptor Blockers:
- Clopidogrel
- Ticagrelor
- Prasugrel
- Ticlopidine
- GP2b/3a Inhibitors:
- Abciximab
- Eptifibatide
- Tirofiban
- PDE-3 Inhibitors:
- Cilostazol
- Anticoagulants, Thrombolytics, Antiplatelet Agents MOA
- Therapeutic Indications
- Adverse Drug Reactions (ADR's)
- Drug Complications
To follow along with Notes & Illustrations for our podcasts please become a member on our website! https://www.ninjanerd.org/podcast/anticoagulants-thrombolytics-and-antiplatelet-agents
Follow us on:
For the best experience, listen in Metacast app for iOS or Android